Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib

Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib

Qiansong Cheng,1,2 Jing Wang,2 Chenglan Lv,2 Jingyan Xu2 1Department of Hematology, The Lu’an People’s Hospital, The Lu’an Hospital Affiliated to Anhui Medical University, Lu’an, Anhui, People’s Republic of China; 2Department of Hematology, The Affil...

Full description

Bibliographic Details
Main Authors: Cheng Q, Wang J, Lv C, Xu J
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:OncoTargets and Therapy
Subjects:
primary central nervous system lymphoma
bruton’s tyrosine kinase
zanubrutinib
targeted therapy
Online Access:https://www.dovepress.com/successful-management-of-a-patient-with-refractory-primary-central-ner-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/successful-management-of-a-patient-with-refractory-primary-central-ner-peer-reviewed-fulltext-article-OTT

Similar Items